Stockreport

Mineralys Therapeutics GAAP EPS of -$0.40 beats by $0.13 [Seeking Alpha]

Mineralys Therapeutics, Inc.  (MLYS) 
PDF Cash, cash equivalents, and investments were $656.6 million as of December 31, 2025, compared to $198.2 million as of December 31, 2024. The company believes that its c [Read more]